James Edward Doyle - 09 Oct 2025 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
Director
Signature
/s/ James Edward Doyle by Mark Busch, attorney-in- fact
Issuer symbol
EXAS
Transactions as of
09 Oct 2025
Net transactions value
-$120,000
Form type
4
Filing time
10 Oct 2025, 17:25:29 UTC
Previous filing
14 Aug 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Doyle James Edward Director EXACT SCIENCES CORP., 5505 ENDEAVOR LANE, MADISON /s/ James Edward Doyle by Mark Busch, attorney-in- fact 10 Oct 2025 0001614265

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXAS Common Stock Sale $120,000 -2,000 -3.3% $60.00 57,962 09 Oct 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale reported in this field was effected pursuant to a Rule 10b5-1 trading plan entered into on March 9, 2025.